Rare and emerging fungal pulmonary infections

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 2, 2008, Pages 121-131

  Varkey, Jay B ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hyalophyphomycosis; Phaeohyphomycosis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; PREDNISONE; VORICONAZOLE;

ACREMONIUM; BRONCHOPULMONARY ASPERGILLOMA; CENTRAL NERVOUS SYSTEM INFECTION; CHROMOMYCOSIS; DRUG MEGADOSE; FUNGAL COLONIZATION; FUNGUS ISOLATION; FUSARIUM; GEOTRICHUM; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; KERATITIS; LUNG MYCOSIS; MYCETOMA; PAECILOMYCES; PHAEOHYPHOMYCOSIS; PNEUMONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SCEDOSPORIUM; SINUSITIS; STEROID THERAPY; TISSUE DIFFERENTIATION; TREATMENT DURATION; TRICHODERMA; TRICHOSPORON;

ANTIFUNGAL AGENTS; DEBRIDEMENT; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL;

EID: 41149124598     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1063851     Document Type: Review

References (99)

1. Nucci M, Anaissie E. Emerging fungi. Infect Dis Clin North Am 2006;20:563-579
2. Fleming R, Walsh T, Anaissie E. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002;16:915-933
3. Walsh T, Groll R, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004;10(Suppl 1):48-66
4. Siebenmann F. Die Schimmelmykosen des menschlichen Ohres. Wiesbaden: Bergmann; 1889:95
5. Shear C. Life history of an undescribed ascomycete isolated from a granular mycetoma of man. Mycologia 1922;14:239-243
6. Green W, Adame T. Mycetoma in the United States: a review and report of seven additional cases. Am J Clin Pathol 1964;42:75-91
7. Lavy D, Morin O, Venet G, et al. Pseudallescheria boydii knee arthritis in a young immunocompetent adult two years after a compound patellar fracture. Joint Bone Spine 2001;68:517-520
8. Tirado-Miranda R, Solera-Santos J, Brasero J, et al. Septic arthritis due to Scedosporium apiospermum: case report and review. J Infect 2001;43:210-212
9. Arnett J, Hatch H. Pulmonary allescheriasis: report of a case and review of the literature. Arch Intern Med 1975;135:1250-1253
10. Miller M, Greenberger P, Amerian R, et al. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am Rev Respir Dis 1993;148:810-812
11. de Hoog G, Marvin-Sikkema F, Lahpoor G. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans. Mycoses 1994;37(3-4):71-78
12. Hachimi-Idrissi S, Willemsen M, Desprechins B, et al. Pseudallescheria boydii and brain abscesses. Pediatr Infect Dis J 1990;9:737-741
13. Ruchel R, Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995;38:473-475
14. Buzina W, Feierl G, Haas D, et al. Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature. Med Mycol 2006;44:473-477
15. Berenguer J, Diaz-Mediavilla J, Urra D, Munoz P. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis 1989;11:890-896
16. Dworzack D, Clark R, Borkowski W, et al. Pseudallescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine 1989;68:218-224
17. Willinger B, Obradovic A, Selitsch B, et al. Detection and identification of fungi from fungus balls of the maxillary sinus by molecular techniques. J Clin Microbiol 2003;41:581-585
18. Gallagher J, Dodds Ashley E, Drew R, Perfect J. Antifungal pharmacotherapy for invasive mould infections. Expert Opin Pharmacother 2003;4:147-164
19. Mellinghoff I, Winston D, Mukwaya G, Schiller G. Treatment of Scedosporium apiospermum brain abscess with posaconazole. Clin Infect Dis 2002;34:1648-1650
20. Malloch D, Salkin I. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984;21:247-255
21. Liu K, Howell D, Perfect J, Schell W. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998;109:45-54
22. Capilla J, Yustes C, Mayayo E, et al. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother 2002;46:3323-3326
23. Nelson P, Dignani M, Anaissie E. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994;7:479-504
24. Liesegang T, Forster P. Spectrum of microbial keratitis in south Florida. Am J Ophthalmol 1980;90:38-47
25. Rosa R, Miller D, Alfonso E. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994;101:1005-1013
26. Tanure M, Cohen E, Sudesh S, Rapuano C, Laibson P. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000;19:307-312
27. Saw S, Ooi P, Tan D, et al. Risk factors for contact lens-related Fusarium keratitis: a case-control study in Singapore. Arch Ophthalmol 2007;125:611-617
28. Centers for Disease Control and Prevention (CDC). Update: Fusarium keratitis: United States, 2005-2006. MMWR Morb Mortal Wkly Rep 2006;55:563-564
29. Anaissie E, Nelson P, Beremond M. Fusarium-caused hyalohyphomycosis: an overview. Curr Top Med Mycol 1992;4:231-249
30. Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995;14:741-754
31. Nucci M, Anassie E. Cutaneous infection by Fusarium species in normal and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002;35:909-920
32. Wheeler M, McGinnis M, Schell W, Walker D. Fusarium infection in burned patients. Am J Clin Pathol 1981;75:304-311
33. Sturm A, Grave W, Kwee W. Disseminated Fusarium oxysporium infection in patient with heatstroke. Lancet 1989;1(8644):968
34. Anaissie E, Kuchar R, Rex J, et al. Fusariosis and pathogenic Fusarium species in a hospital water system: a new paradigm for the epidemiology of opportunistic mould infections. Clin Infect Dis 2001;33:1871-1878
35. Boutati E, Anaissie E. Fusarium a significant emerging pathogen in patients with hematologic malignancy: ten years experience at a cancer center and implication for management. Blood 1997;90:999-1008
36. Anaissie E, Hachem R, Legrand C, Legenne P, Nelson P, Bodey G. Lack of activity of amphotericin B in systemic murine fusarial infections. J Infect Dis 1992;165:1155-1157
37. Perfect J, Marr K, Walsh T, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-1131
38. Garnis A, Gudnanson T, Giebink G, Ramsay N. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991;13:1077-1088
39. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;1(Suppl):7-15
40. Hennequin C, Lavarde V, Poirot J, et al. Invasive Fusarium infections: a retrospective survey of 31 cases. J Med Vet Mycol 1997;35:107-114
41. Stanzani M, Vianelli N, Bandini G, et al. Successful treatment of disseminated fusariosis after allogenic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006;53:e243-e246
42. Ho D, Lee J, Rosso F, Montoya J. Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses 2007;50:227-231
43. Raad I, Hachem R, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006;42:1398-1403
44. Schell W, Perfect J. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 1996;34:1333-1336
45. Herbrecht R, Letscher-Bru V, Fohrer C, et al. Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur J Clin Microbiol Infect Dis 2002;21:814-817
46. Bainier G. Mycothèque de l'école de Pharmacie, XI Paecilomyces, genre noveau de Mucédinées. Bull Soc Mycol Fr 1907;23:26-27
47. Byrd R, Roy T, Fields C, Lynch J. Paecilomyces variotii pneumonia in a patient with diabetes mellitus. J Diabetes Complications 1992;6:150-153
48. Salle V, Lecuyer E, Chouaki T, et al. Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review. J Infect 2005;51:e93-e95
49. Tan T, Ogden A, Tillman J, Demmler G, Rinaldi M. Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient. J Clin Microbiol 1992;30:2479-2483
50. Chan-Tack K, Thio C, Miller N, Karp C, Ho C, Merz W. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 1999;37:57-60
51. French F, Mallia C. Pleural effusion caused by Penicillium lilacinum. Br J Dis Chest 1972;66:284-290
52. Dharmasena F, Davies G, Catovsky D. Paecilomyces variotii pneumonia complicating hairy cell leukaemia. Br Med J (Clin Res Ed) 1985;290:967-968
53. Akhunova A, Shustova V. Paecilomyces infection. Probl Tuberk 1989;8:38-42
54. Bryant D, Rogers P. Allergic alveolitis due to woodrot fungi. Allergy Proc 1991;12:89-94
55. Hilmarsdottir I, Thorsteirsson S, Asmundsson P, et al. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis 2000;32:331-332
56. Martin C, Roberts S, Greenberg R. Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2002;35:e78-e81
57. De Miguel D, Gomez P, Gonzalez R, et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005;53:33-37
58. Chouaki T, Lavarde V, Lachaud L, et al. Invasive infections due to Trichoderma species: report of 2 cases, finding of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002;35:1360-1367
59. Richter S, Cormican M, Pfaller M, et al. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol 1999;37:1154-1160
60. Walsh T, Melcher G, Rinaldi M, et al. Trichosporon beigellii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990;28:1616-1622
61. Arikan S, Hascelik G. Comparisons of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates. Diagn Microbiol Infect Dis 2002;43:107-111
62. Paphitou N, Ostrosky-Zeichner L, Paetznick V, Rodriguez J, Chen E, Rex J. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002;46:1144-1146
63. Bouakline A, Lacroix C, Roux N, Gangneux J, Derouin F. Fungal contamination of food in hematology units. J Clin Microbiol 2000;38:4272-4273
64. Martino R, Salavert M, Parody R, et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis 2004;38:335-341
65. Kassamali H, Anaissie E, Ro J, et al. Disseminated Geotrichum candidum infection. J Clin Microbiol 1987;25:1782-1783
66. Pfaller M, Diekema D. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-4431
67. Venditti M, Posteraro B, Morace G, Martino P. In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemother 1991;3:13-15
68. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998;36:198-202
69. deAlmeida B, Moreria Lemos A, Severe L. Acute pulmonary adiaspiromycosis: report of three cases and a review of 16 other cases collected from the literature. Rev Iberoam Micol 1997;14:177-180
70. Sun Y, Bhuiya T, Wasil T, Macia A, Wasserman P. Fine needle aspiration of pulmonary adiaspiromycosis: a case report. Acta Cytol 2007;51:217-221
71. Pluss J, Opal S. Pulmonary sporotrichosis: review of treatment and outcome. Medicine 1986;65:143-153
72. Cheng N, Wong W, Fung C, Liu C. Unusual pulmonary manifestations of disseminated Penicillium marneffei infection in three AIDS patients. Med Mycol 1998;36:429-432
73. Radford S, Johnson E, Warnock D. In vitro studies of activity of voriconazole (UK-109,496): a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997;41:841-843
74. Hospenthal D. Agents of chromoblastomycosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005: 2988-2991
75. Esterre P, Inzan C, Ratsioharana M, et al. A multicentre trial of terbinafine in patients with chromoblastomycosis: effect on clinical and biologic criteria. J Dermatolog Treat 1998;9:S29-S34
76. Hospenthal D. Uncommon fungi. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005:3070-3072
77. Koga T, Matsuda T, Matsumoto T, Furue M. Therapeutic approaches to subcutaneous mycoses. Am J Clin Dermatol 2003;4:537-543
78. Matsumoto T, Ajello L. Agents of phaeohyphomycosis. In: Collier L, Balows A, Sussman M, eds. Topley & Wilson's Microbiology and Microbial Infections. 9th ed. London: Arnold; 1998:503-524
79. Garg P, Gopinathan U, Choudhary K, Rao G. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000;107:574-580
80. Wilhelmus K, Jones D. Curvularia keratitis. Trans Am Ophthalmol Soc 2001;99:111-132
81. deShazo R, Chapin K, Swain R. Fungal sinusitis. N Engl J Med 1997;337:254-259
82. Corey J, Delsupehe K, Ferguson B. Allergic fungal sinusitis: allergic, infectious, or both? Otolaryngol Head Neck Surg 1995;113:110-119
83. Klossek J, Serrano E, Peloquin L, Percodani J, Fontanel J, Pessey J. Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses. Laryngoscope 1997;107:112-117
84. Greenberger P. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-692
85. Borges M, Warren S, White W, Pellettiere E. Pulmonary phaeohyphomycosis due to Xylohypha bantiana. Arch Pathol Lab Med 1991;115:627-629
86. Revankar S, Sutton D, Rinaldi M. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004;38:206-216
87. Revankar S, Patterson J, Sutton D, Pullen R, Rinaldi M. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002;34:467-476
88. Negroni R, Helou S, Petri N, Robles A, Arechavala A, Bianchi M. Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin Infect Dis 2004;38:e15-e20
89. Morris A, Schell W, McDonagh D, Chafee S, Perfect J. Fonsecaea pedrosoi pneumonia and Emericella nidulans cerebral abscesses in a bone marrow transplant patient. Clin Infect Dis 1995;21:1346-1348
90. Verweij PE, van Kasteren M, van de Nes J, de Hoog GS, de Pauw BE, Meis JFGM. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J Clin Microbiol 1997;35:2675-2678
91. Balis E, Velegraki A, Fragov A, Pefanis A, Kalabokas T, Mountokalakis T. Lung mass caused by Phoma exigua. Scand J Infect Dis 2006;38:552-553
92. Gurcan S, Tugrul H, Yoruk Y, Ozer B, Tatman-Otkun M, Otkun M. First case report of empyema caused by Beauveria bassiana. Mycoses 2006;49:246-248
93. Endo S, Hironaka M, Murayama F, Yamaguchi T, Sohara Y, Saito K. Scopulariopsis fungus ball. Ann Thorac Surg 2002;74:926-927
94. Brenner S, Morgan J, Rickert P, Rimland D. Cladophialophora bantiana isolated from an AIDS patient with pulmonary infiltrates. J Med Vet Mycol 1996;34:427-429
95. Keyser A, Schmid F, Linde H, Merk J, Birnbaum D. Disseminated Cladophialophora bantiana infection in a heart transplant recipient. J Heart Lung Transplant 2002;21:503-505
96. Shigehara K, Takahashi K, Tsunematsu K, et al. A case of Trichosporon pullulans infection of the lung with adult T-cell leukemia. Jpn J Med 1991;30:135-137
97. Qadri S, Ellis M. Localized pulmonary disease due to Trichosporon beigelii. J Natl Med Assoc 1992;84:449-452
98. Kenney R, Kwon-Chung K, Waytes A, et al. Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect Dis 1992;14:235-242
99. Kenney R, Kwon-Chung K, Witebsky F, Melnick D, Malech H, Gallin J. Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease. Am J Clin Pathol 1990;94:344-350